Find Loprazolam Mesilate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Loprazolam mesilate, Dormonoct, Loprazolam methanesulfonate, Somnovit, Sonin, Havlane
Molecular Formula
C24H25ClN6O6S
Molecular Weight
561.0  g/mol
InChI Key
DDSDPQHQLNAGLJ-YEBWQKSTSA-N
FDA UNII
VKF8383J65

Loprazolam Mesilate
1 2D Structure

Loprazolam Mesilate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2Z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one;methanesulfonic acid
2.1.2 InChI
InChI=1S/C23H21ClN6O3.CH4O3S/c1-27-8-10-28(11-9-27)14-19-23(31)29-20-7-6-15(30(32)33)12-17(20)22(25-13-21(29)26-19)16-4-2-3-5-18(16)24;1-5(2,3)4/h2-7,12,14H,8-11,13H2,1H3;1H3,(H,2,3,4)/b19-14-;
2.1.3 InChI Key
DDSDPQHQLNAGLJ-YEBWQKSTSA-N
2.1.4 Canonical SMILES
CN1CCN(CC1)C=C2C(=O)N3C(=N2)CN=C(C4=C3C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C5Cl.CS(=O)(=O)O
2.1.5 Isomeric SMILES
CN1CCN(CC1)/C=C\2/C(=O)N3C(=N2)CN=C(C4=C3C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C5Cl.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
VKF8383J65
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 8-nitro-6-(o-chlorophenyl)-1,2-dihydro-2-(n-methylpiperazin-1-yl)methylene-1h,4h-imidazo (1,2-a)(1,4)benzodiazepin-1-one Methanesulfonate

2. Hr 158

3. Hr 458

4. Loprazolam

5. Ru 31158

6. Triazulenone

7. Triazulenone Mesylate

8. Triazulenone, (z)-isomer

2.3.2 Depositor-Supplied Synonyms

1. Loprazolam Mesilate

2. Dormonoct

3. Loprazolam Methanesulfonate

4. Somnovit

5. Sonin

6. Havlane

7. 70111-54-5

8. Ru-31158

9. Vkf8383j65

10. Hr-158

11. Triazulenone Mesylate

12. Unii-vkf8383j65

13. Havlane (tn)

14. Hr 158

15. Schembl352745

16. 61197-93-1

17. Loprazolam Mesilate [mart.]

18. Loprazolam Mesilate [who-dd]

19. Loprazolam Methanesulfonate [mi]

20. D08145

21. Q27291872

22. (2z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4h-imidazo[1,2-a][1,4]benzodiazepin-1-one;methanesulfonic Acid

23. (z)-6-(2-chlorophenyl)-2-((4-methylpiperazin-1-yl)methylene)-8-nitro-2,4-dihydro-1h-benzo[f]imidazo[1,2-a][1,4]diazepin-1-one Methanesulfonate

24. 1h-imidazo(1,2-a)(1,4)benzodiazepin-1-one, 6-(2-chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-, (2z)-, Methanesulfonate (1:1)

25. 1h-imidazo(1,2-a)(1,4)benzodiazepin-1-one, 6-(2-chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-, Monomethanesulfonate

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 561.0 g/mol
Molecular Formula C24H25ClN6O6S
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count2
Exact Mass560.1244814 g/mol
Monoisotopic Mass560.1244814 g/mol
Topological Polar Surface Area160 Ų
Heavy Atom Count38
Formal Charge0
Complexity984
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty